IL17A and Crohn disease: However, Th17 cells’ complex polarity and epithelial barrier integrity may not be the only possible explanation for the failure of anti-IL-17A therapy in Crohn’s disease, because RORγt+ innate lymphoid cells (ILCs) also produce IL-17A18.